Manufacturer record

Durgaji Healthcare Pvt.Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Durgaji Healthcare Pvt.Ltd (Uttarakhand) were declared Not of Standard Quality between March 2026 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: DHPLT/030725, Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Hydrochloride Tablets (exp Jun 2027). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Acts and rules 1945 with respect to test for 'Disintegration Time'. Listed in the September 2026 alert.

Records by type

2 records linked to Durgaji Healthcare Pvt.Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Mar 2026 to Sep 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2026
2
Products affected
Dissolution
Most common failure
Sep 2026
Latest alert

Flagged batches per year

2026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Hydrochloride Tablets Batch DHPLT/030725Mfg Jul 2025 · Exp Jun 2027 The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Acts and rules 1945 with respect to test for 'Disintegration Time' and is also not of standard quality for the reason stated under 'Description'.Description CDL, KolkataCDSCO lab Sep 2026
Pantoprazole IP 40 mg Tablets Batch DHPLT/040525Mfg May 2025 · Exp Apr 2027 The sample does not conform to IP with respect to test for Dissolution (Buffer Stage)Dissolution CDL, KolkataCDSCO lab Mar 2026

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.